Provided by Tiger Fintech (Singapore) Pte. Ltd.

The European Equity Fund Inc

9.66
+0.05000.52%
Volume:1.37K
Turnover:13.20K
Market Cap:64.72M
PE:-32.91
High:9.69
Open:9.68
Low:9.62
Close:9.61
Loading ...

Brickwood Asset Management Selects Northern Trust for Asset Servicing Solutions

Business Wire
·
03 Mar

XPENG Sets New Benchmark in Indonesia, Becoming the Most Intelligent EV Brand in the Market

GlobeNewswire
·
03 Mar

XPENG appoints Hedin Mobility Group as distributor and importer for Switzerland, the Czech Republic and Slovakia

GlobeNewswire
·
28 Feb

XPENG appoints Inchcape as its distributor and strategic partner for Poland

GlobeNewswire
·
27 Feb

Marqeta Reports Fourth Quarter and Full Year 2024 Financial Results

Business Wire
·
27 Feb

Recruitment Spotlight: Phase 3 Clinical Trial of Novel Prostate Cancer Radiopharmaceutical Now Active in Miami

GlobeNewswire
·
25 Feb

How OKX Achieved MiCA Compliance and What It Means for Users Across Europe

BE[IN]CRYPTO
·
20 Feb

XPENG announces its official launch in the UK, showcasing smart mobility lineups including world's first AI-defined vehicle and flying car

GlobeNewswire
·
12 Feb

Coinbase Gains FCA Approval Strengthening UK Market Presence

CoinMarketCap
·
04 Feb

Kraken Bows to MiCA, Drops Five Stablecoins including USDT

CoinMarketCap
·
02 Feb

Crypto.com Becomes the First Crypto Asset Service Provider to Receive a Full MiCA Licence

BE[IN]CRYPTO
·
28 Jan

OKX and Crypto.com Secure MiCA Licenses, Transforming Crypto in Europe

CoinMarketCap
·
28 Jan

Crypto.com Receives Markets in Crypto Assets (MiCA) Licence

CoinMarketCap
·
28 Jan

OKX secures MiCA pre-authorization, paving the way for localized crypto services

CoinMarketCap
·
24 Jan

Junshi Biosciences Announces Commercialization Partnership with LEO Pharma for Toripalimab in Europe

GlobeNewswire
·
20 Jan

Guess which ASX 200 stock is jumping to record high on big European news

MotleyFool
·
17 Jan

Illuccix® Receives European Approval

GlobeNewswire
·
17 Jan

iECURE Reports Complete Clinical Response in First Infant Dosed with its In Vivo Gene Editing Candidate ECUR-506 in an Ongoing Phase 1/2 Clinical Trial in Ornithine Transcarbamylase (OTC) Deficiency

Business Wire
·
09 Jan

XPENG selects RTI Connext Drive to Streamline Communication for its Next-Generation Vehicle Architecture

GlobeNewswire
·
06 Jan

Coinbase Acquires BUX’s Cyprus Unit, Signaling Potential Entry into CFDs

BE[IN]CRYPTO
·
04 Jan